Several transcriptomic analyses have demonstrated that TPM2 expression is increased approximately 4- to more than 6-fold in HBV-associated HCC or acute liver failure, respectively (Hass et al., 2016; Chen et al., 2018). The gene discussed is TPM2; the disease is hepatocellular carcinoma.